Changes in Metabolic Activity, and Gait Function by Dual-task Cognitive Game-based Treadmill Intervention in Parkinson's Disease.
CMAGDT
1 other identifier
interventional
67
1 country
1
Brief Summary
The present proposal will evaluate the neural underpinnings of (a) the decline of mobility function in Parkinson's disease (PD), and (b) the effects of an innovative computer-guided dual-task (DT) mobility training platform (complementary approach: exercise intervention). Improved mobility functioning in PD, specifically balance, gait and cognition, directly translates to improved community ambulation as well as increased physical activity and social participation. These benefits are known to have a significant preventive and disease-modifying impact that surpasses any currently available pharmacological interventions. Outcomes of this research will provide new insights into brain plasticity mechanisms and will accelerate further optimization and commercialization of multi-modal mobility-cognitive training applications along with accompanying smart electronic monitoring tools. With wider usage of this training platform, rehabilitation specialists will be able to effectively scale services, while still monitoring quality and ensuring accountability. Thus, the study is highly transformative.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Jun 2021
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedMay 11, 2021
May 1, 2021
2.2 years
May 28, 2020
May 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
NDWP scores
NDWP scores on PET scans of participants will be analysed to identify gait impairment related imagining signatures during single and dual-task walking, and after intervention. They will also be compared to age-matched healthy controls using student t-test.
10 weeks
Step Length Coefficient of Variability
10 weeks
Study Arms (3)
Dual-task walking Intervention
EXPERIMENTALConventional Gait Rehabilitation
ACTIVE COMPARATORHealthy Controls
NO INTERVENTIONInterventions
Participants will be expected to play several cognitive computer games while standing on a sponge pad (10-min warm-up and while walking on the treadmill at your self-selected comfortable speed. (Dual-task treadmill training). This would be done in intervals of 2-4 min with rest periods for a total time of 35 minutes Treadmill speed and the difficulty level of the cognitive games will progress depending on participant performance and comfort level.
Participants will undergo a mixture of current gait training programs available for people with Parkinson's Disease. The protocol will be a Warm-up exercise consisting of rhythmical large movements (10 minutes), as well as video game practice while standing (i.e., single-task; 10 minutes). Treadmill walking in intervals of 2-4 minutes with rest periods. Walking over the ground while negotiating through obstacles. (10 minutes) The speed of the treadmill will be progressed gradually and as tolerated.
Eligibility Criteria
You may qualify if:
- Diagnosed with idiopathic PD, defined by the UK Brain Bank criterion in disease stage 2 - 3 (classified by Hoehn and Yahr scale),
- Montreal cognitive assessment (MoCA) scores to be 25 or higher
- Age 55-70 years
- Stable medications for Parkinson over the past 3 months
- Able to walk at least 50m without any assistive device
- Episode of FOG in the past 6 months
You may not qualify if:
- The presence of neurological conditions other than PD affecting cognitive abilities.
- Any orthopedic impairment affecting gait and balance.
- Any cardiovascular impairment limiting the ability to walk for 10-15 minutes on a treadmill;
- Abnormal MRI
- General contraindications.
- Age 55-70 years,
- Independent community living,
- Not receiving any home care or Physiotherapy,
- Walking outdoors for exercise for at least 3 times per week,
- No neurological conditions affecting mobility or affecting cognitive abilities,
- Any orthopedic impairment affecting gait and balance.
- Any cardiovascular impairment limiting the ability to walk for 10-15 minutes on a treadmill.
- Abnormal MRI and
- General contraindications for PET and MRI including severe dyskinesia, diabetes, cardiac pacemakers.
- Any orthopedic impairment affecting gait and balance.
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- Weston Brain Institutecollaborator
Study Sites (1)
College of Rehabilitation Sciences, University of Manitoba
Winnipeg, Manitoba, R3E 0T6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 28, 2020
First Posted
June 4, 2020
Study Start
June 1, 2021
Primary Completion
August 1, 2023
Study Completion
November 1, 2023
Last Updated
May 11, 2021
Record last verified: 2021-05